Description
BSE announces listing of additional securities issued by 19 companies under Employee Stock Option Plans, effective September 8, 2025.
Summary
BSE has announced the listing of further securities issued by 19 companies under Employee Stock Option Plans (ESOP) and Employee Stock Option Schemes (ESOS). These securities will be listed and admitted for trading on the exchange effective Monday, September 8, 2025.
Key Points
- 19 companies are issuing additional securities under ESOP/ESOS
- Total securities range from 2,384 shares (RateGain) to 2,309,228 shares (SBFC Finance)
- Face values vary from ₹1 to ₹10 per share
- All securities are not under lock-in period (marked as NA)
- Trading commences September 8, 2025
Companies and Share Details
Major Issuances:
- SBFC Finance Limited: 2,309,228 shares (₹10 face value)
- Tata Motors Ltd: 306,071 shares (₹2 face value)
- Home First Finance: 254,550 shares (₹2 face value)
- J.B. Chemicals: 140,236 shares (₹1 face value)
- AXIS Bank: 131,047 shares (₹2 face value)
Other Notable Companies:
- Capital India Finance, Chalet Hotels, Cholamandalam Investment, Computer Age Management Services, Dr. Reddy’s Laboratories, E.I.D. Parry, ICICI Lombard General Insurance, Navin Fluorine International, Nuvama Wealth Management, Prime Securities, RateGain Travel Technologies, TVS Supply Chain Solutions, Zaggle Prepaid Ocean Services
Regulatory Changes
No new regulatory changes introduced. This is a standard listing procedure for ESOP/ESOS securities.
Compliance Requirements
- Trading members are informed of the new listings
- Securities are available for trading from the specified effective date
- Companies must comply with standard listing requirements
Important Dates
- Notice Date: September 5, 2025
- Trading Commencement: Monday, September 8, 2025
- Lock-in Period: Not applicable for all listed securities
Impact Assessment
Minimal market impact expected as these are routine ESOP listings. The additional shares may marginally increase the float for the respective companies but are unlikely to significantly affect stock prices due to the relatively small quantities involved compared to existing share capital.
Impact Justification
Routine ESOP listing affecting multiple companies with minimal market impact